Mint Venture Partners recovers principal and target return five years after forming its first fund
Summary
Mint Venture Partners says it has recovered its principal and target return from its first fund five years after formation. The result came after three portfolio companies, Organoid Sciences, AimedBio, and Meju, listed on KOSDAQ. The firm also says it is preparing two new funds and plans to expand investments into AI healthcare, drug development, diagnostics, and precision medicine. In addition to investing, it runs a venture studio that co-founds companies with doctors and researchers and seeks strategic partners for future joint startups.
Funding
Amount
-
Total raised
Date
May 1, 2025
Announcement date
Investors
-
Lead investors
Company
organoidrx.com
Funded company
AskAI Classifications
Sectors
HealthTech
Medical Management
General Healthcare software
Functions
Internet of Things (IoT) Platforms
General IoT
Linked Companies
ORGANOIDSCIENCES
$1M to $5M
MEZOO
up to $1M